Ariva debate
This article was originally published in The Tan Sheet
Executive Summary
Star Scientific's Internet monitoring program to prevent tobacco distributors from selling its Ariva "cigalett" is inadequate, because at least five Web sites still sell the product, GlaxoSmithKline says in June 14 comments to FDA; the firm has submitted a citizen petition claiming Ariva is an adulterated food. Star had previously asserted it monitors the Internet to prevent Web sales of Ariva (1"The Tan Sheet" May 13, 2002, p. 8). In its own June 13 comments, Star requests a citizen petition filed by the Society for Research on Nicotine & Tobacco be denied "because it states no grounds upon which to predicate FDA jurisdiction" over Ariva. SRNT has "significant relationships with the drug industry, including GSK," Star says, asserting the group is advocating regulation of Ariva because it "appears to be perceived as a threat" to GSK's NiQuitin CQ lozenge, for which GSK is seeking FDA approval...
You may also be interested in...
Star Scientific Defends Ariva As “Compressed Version” Of Dry Snuff
Ariva "cigalett" pieces should be classified as a smokeless tobacco product and not a food despite containing ingredients other than tobacco such as sweeteners and natural and artificial flavorings, marketer Star Scientific contends
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.